Claims for Patent: 4,670,394

Summary for Patent: 4,670,394

Title:	Isolation and culture of adrenal medullary endothelial cells producing blood clotting factor VIII:C
Abstract:	The present invention discloses a new line of endothelial cell of adrenal medullary origin capable of producing blood clotting Factor VIII:C. A method of isolating and culturing said cell line has also been disclosed. Factor VIII:C is useful in treating hemophilia.
Inventor(s):	Pollard; Harvey B. (Potomac, MD), Ornberg; Richard (Bethesda, MD), Banerjee; Dipak (Rockville, MD), Youdim; Moussa (Rockville, MD), Lelkes; Peter (Rockville, MD), Heldman; Eli (Rockville, MD)
Assignee:	The United States of America as represented by the Secretary of the (Washington, DC)
Application Number:	06/672,451
Patent Claims:	1. A biologically pure culture of a profusely and continuously growing endothelial cell line of adrenal medullary origin. 2. The cell line of claim 1 having the properties of American Type Culture Collection accession number CRL 8659. 3. The cell line of claim 1 being of bovine adrenal medullary origin. 4. The cell line of claim 1 which produces blood clotting Factor VIII:C in recoverable amounts. 5. The cell line of claim 1 profusely and continuously growing on plastic surface in a nutrient culture medium unsupplemented with growth promoters. 6. A method of in vitro culturing of adrenal medullary endothelial cells comprising the steps of dissociating adrenal medullary cells from an adrenal gland, and allowing said cells to proliferate in a medium and environment suitable for the growth of said cells to form recoverable amounts of continuously growing adrenal medullary cells, and then isolating therefrom said endothelial cells. 7. The method of claim 6 wherein dissociating comprises treating said adrenal gland with collagenase. 8. The method of claim 6 wherein said medium comprises minimal essential medium supplemented with about 10% heat inactivated fetal calf serum, about 2mM glutamine and suitable amount of antibiotic to prevent growth of undesirable organisms. 9. The method of claim 8 wherein said cells are incubated at about 37.degree. C. for about 3 hours in said medium. 10. The method of claim 6 wherein said endothelial cells produce blood-clotting Factor VIII:C in recoverable amounts.

Details for Patent 4,670,394

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2039-03-29